Compass Therapeutics (CMPX) Other Gross PP&E Adjustments (2023 - 2025)
Compass Therapeutics (CMPX) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with -$2.4 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 13782.35% to -$2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, down 13782.35% year-over-year, with the annual reading at -$2.4 million for FY2025, 13782.35% down from the prior year.
- Other Gross PP&E Adjustments hit -$2.4 million in Q4 2025 for Compass Therapeutics, up from -$2.7 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $6.0 million in Q2 2024 to a low of -$3.1 million in Q2 2025.
- Historically, Other Gross PP&E Adjustments has averaged $2.0 million across 3 years, with a median of $2.4 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: rose 27.9% in 2024 and later tumbled 13782.35% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $5.4 million in 2023, then plummeted by 100.32% to -$17000.0 in 2024, then crashed by 13782.35% to -$2.4 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CMPX at -$2.4 million in Q4 2025, -$2.7 million in Q3 2025, and -$3.1 million in Q2 2025.